Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011881 (diabetic nephropathy)
 10,836 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Measurement of sialic acid and acute phase reactant (APR) proteins in sera of patients with diabetic nephropathy was performed. Twenty-six patients with non-insulin-dependent diabetes mellitus (NIDDM) were examined. The levels of sialic acid in sera, with or without treatment of neuraminidase, were measured by the thiobarbiturate method. The levels of alpha 1-antitrypsin (alpha 1-AT), alpha 1-acid glycoprotein (alpha 1-AG) or alpha 2-macroglobulin (alpha 2-MG) were measured by laser nephelometry. The levels of sialic acid or APR proteins in sera of patients with diabetic nephropathy were increased markedly. There was a significant correlation between the levels of sialic acid and those of alpha 1-AT in sera of patients with NIDDM. The mobility of alpha 1-AT in sera of patients with NIDDM treated with neuraminidase was decreased markedly in the immunofixation test. It is suggested that the increase of APR proteins in diabetic sera is mainly composed of sialic acid in patients with NIDDM with or without nephropathy.
 ...
PMID:Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. 246 54

The levels of immunoglobulins, complement components and APR proteins including alpha 1-antitrypsin (alpha 1-AT), alpha 1-acid glycoprotein (alpha 1-AG), alpha 2-macroglobulin (alpha 2-MG) and haptoglobin (Hpt) in the sera, as well as glycosylated or nonglycosylated protein fractions of these proteins in the sera, were examined by laser nephelometry in 49 patients with diabetes mellitus. Immunofluorescence studies of immunoglobulins, beta-lipoprotein (beta-Lp), complement components and APR proteins in the kidney and skin tissues of patients with diabetic nephropathy were performed to elucidate whether such factors might play a role in the development of the vascular changes in this disease. The levels of alpha 1-AT and alpha 2-MG in the sera as well as glycosylated or nonglycosylated protein fractions of these proteins in the sera from patients with diabetic nephropathy, were significantly greater than those in healthy adults. Marked linear deposition of these proteins in the glomerular or dermal vascular walls was observed in the same patients. In particular, IgG and alpha 1-AT were accumulated in the glomeruli of patients with the nodular type of this disease. The intensity of alpha 1-AT or IgG deposition in glomerular capillary walls treated with a high concentration (4 mol) of NaCl was markedly decreased in such patients. It appeared that serum APR proteins with or without glycosylation underwent exudation into the glomerular and dermal vascular walls, and then accumulated in these walls in patients with diabetic nephropathy.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Immunopathological analysis of acute phase reactant (APR) proteins in glomeruli from patients with diabetic nephropathy. 247

The solubilization of renal deposits of IgG and other serum proteins by fresh human sera or human gamma-globulin was studied in patients with diabetic nephropathy. Renal biopsy specimens were from 10 patients with diabetic nephropathy. These specimens were incubated with fresh sera obtained from the same patients and healthy adults or human gamma-globulin at 37 degrees C for 1 hr in plastic test tubes. The sections were stained with FITC-labeled heavy chain specific anti-human IgG, alpha 1-antitrypsin, haptoglobin and beta-lipoprotein antisera, and then examined with a fluorescent microscope. It was demonstrated that fresh human sera or gamma-globulin significantly solubilized glomerular deposits of IgG and other serum proteins in patients with diabetic nephropathy. It was postulated that solubilization of protein deposits in glomeruli requires the same substances detected in vitro in the kidney tissues from patients with diabetic nephropathy.
 ...
PMID:Solubilization of intraglomerular deposits of serum proteins by fresh human sera or gamma-globulin in patients with diabetic nephropathy. 608 25